Antibody pattern and other criteria for diagnosis and classification in PSS.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 3258382)

Published in J Rheumatol on January 01, 1988

Authors

R Burgos-Vargas, E Martínez-Cordero, P A Reyes-López, R Herrera-Esparza

Articles by these authors

(truncated to the top 100)

Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis (2009) 4.37

ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol (1999) 2.62

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2010) 2.27

Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55

Anti-avian antibodies and rheumatoid factor in pigeon hypersensitivity pneumonitis. Clin Exp Allergy (2003) 1.45

Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis (2009) 1.42

Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis (2001) 1.25

Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18

Features of spondyloarthritis around the world. Rheum Dis Clin North Am (1998) 1.13

Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol (2003) 1.11

Validation of a Spanish version of the Childhood Health Assessment Questionnaire. J Rheumatol (1997) 1.11

Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis (2005) 1.09

A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis (2002) 1.03

Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) (2006) 1.02

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis (2006) 1.02

Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.99

Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol (1998) 0.98

The final destiny of acantholytic cells in pemphigus is Fas mediated. J Eur Acad Dermatol Venereol (2009) 0.98

Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98

Intradermal tophi in gout: a case-control study. J Rheumatol (1999) 0.97

Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Arthritis Rheum (1999) 0.97

Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis (2002) 0.93

Increased excretion of urinary podocytes in lupus nephritis. Indian J Nephrol (2011) 0.91

Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxford) (2001) 0.90

A sensitive and specific assay to detect Ro(SS-A) and La(SS-B) antibodies. J Invest Dermatol (1986) 0.89

American trypanosomiasis (Chagas' disease) and blood banking in Mexico City: seroprevalence and its potential transfusional transmission risk. Arch Med Res (2000) 0.89

Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus (2009) 0.89

Eye tophi deposition in gout. J Rheumatol (1986) 0.88

The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis. Ann Rheum Dis (1997) 0.88

TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin Exp Rheumatol (2002) 0.88

Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. J Rheumatol (1995) 0.88

Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. Arthritis Rheum (2009) 0.87

Severe tophaceous gout. Characterization of low socioeconomic level patients from México. Clin Exp Rheumatol (2006) 0.87

A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies. Reumatismo (2009) 0.87

Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology (Oxford) (2000) 0.87

HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles. Clin Exp Rheumatol (2005) 0.86

TNFalpha and IL-6 are mediators in the blistering process of pemphigus. Int J Dermatol (2001) 0.86

Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol (2014) 0.85

Anti-idiotype antibodies neutralize in vivo the blistering effect of Pemphigus foliaceus IgG. Scand J Immunol (2001) 0.85

Update on functional assessment tools. J Rheumatol Suppl (2000) 0.84

HLA-DRB1*08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J Rheumatol (1997) 0.83

Widespread expression of inducible NOS and citrulline in lupus nephritis tissues. Inflamm Res (2009) 0.83

Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients. Clin Exp Rheumatol (2009) 0.83

Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2006) 0.83

Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol (1995) 0.82

Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rheumatol (1997) 0.82

Transplacental passage of maternal pemphigus foliaceus autoantibodies induces neonatal pemphigus. J Am Acad Dermatol (2000) 0.82

Transplacental transfer of human antinuclear antibodies in mice by injection of lupus IgG in pregnant animals. J Rheumatol (1990) 0.81

Antibodies to peptidoglycan in juvenile onset ankylosing spondylitis and pauciarticular onset juvenile arthritis associated with chronic iridocyclitis. J Rheumatol (1986) 0.81

[Etiology of infectious endocarditis at the Instituto Nacional de Cardiologia Ignacio Chavez from 1976 to 1986]. Arch Inst Cardiol Mex (1989) 0.81

[Juvenile ankylosing spondylitis: clinical characteristics in 41 patients]. Bol Med Hosp Infant Mex (1985) 0.81

Cellular localization of the Ro/SS-A antigen. Clin Rheumatol (1986) 0.81

Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J Rheumatol (2000) 0.81

Molecular characterization of Ro(SSA) and La(SSB) proteins. J Rheumatol (1986) 0.81

Possible role of Hsp70 in autoantigen shuttling to the dermo-epidermal junction in systemic lupus erythematosus. Reumatismo (2003) 0.81

Association of HLA DRB1 alleles with juvenile idiopathic arthritis in Mexicans. Clin Exp Rheumatol (2010) 0.80

Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis. Ann Rheum Dis (2010) 0.80

The use of methotrexate in children with rheumatic diseases. Clin Exp Rheumatol (2010) 0.80

Multiple duodenum-jejunal diverticula in a case of scleroderma. Clin Exp Rheumatol (1986) 0.80

IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients. Scand J Rheumatol (2002) 0.80

Anti-Ro antibodies in healthy mothers and their newborns. Clin Exp Rheumatol (1987) 0.79

Nucleoprotein autoantibodies in lupus erythematosus. J Invest Dermatol (1985) 0.79

Increase of HLA-DR7 in pigeon breeder's lung in a Mexican population. Clin Immunol Immunopathol (1987) 0.79

Anterior spinal flexion in healthy Mexican children. J Rheumatol (1985) 0.79

Echinococcus granulosus down regulates the hepatic expression of inflammatory cytokines IL-6 and TNF alpha in BALB/c mice. Parasite (2002) 0.79

[Detection of antibodies against Trypanosoma cruzi in blood donors]. Salud Publica Mex (1993) 0.79

Illness trajectories in Mexican children with juvenile idiopathic arthritis and their parents. Rheumatology (Oxford) (2006) 0.79

Circulating lymphocyte subpopulations and activated T and B cells in patients with chagasic and non-chagasic myocardiopathy. Cytometry (1997) 0.79

Defective expression of FasL and Bax in human lung cancer. Clin Exp Med (2003) 0.79

FasL and Bax genes are differentially expressed in acinar epithelium and inflammatory cells of primary Sjögren salivary glands. Minerva Med (2003) 0.79

Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol (2009) 0.78

Development of a radiographic index to assess the tarsal involvement in patients with spondyloarthropathies. Ann Rheum Dis (2002) 0.78

Assessment of quality of life in children with rheumatic disease. J Rheumatol (1999) 0.78

Glomerular expression of Fas ligand and Bax mRNA in lupus nephritis. Autoimmunity (2001) 0.78

Beta1-integrins shedding in a guinea-pig model of chronic asthma with remodelled airways. Clin Exp Allergy (2009) 0.78

The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol (2001) 0.78

Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2. J Clin Immunol (1984) 0.77

Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLA-B27 and characterization as a GroEL-like protein. J Rheumatol (1998) 0.77

A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand J Rheumatol (2012) 0.77

Phosphorylation profiles of 60 kD Ro antigen in synchronized HEp-2 cells. Scand J Rheumatol (1995) 0.77

Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid. J Clin Pathol (2007) 0.77

Increased levels of leukotriene C4 in bronchoalveolar lavage from patients with pigeon breeder's disease. Arch Invest Med (Mex) (1989) 0.77

Human papillomavirus 16/18 infections in lung cancer patients in Mexico. Intervirology (2013) 0.77

[The qualitative approach in health: an alternative to clinical research in rheumatic diseases]. Reumatol Clin (2008) 0.77

Intracellular antigens released from Balb/c mice kidneys under chemically induced apoptosis and/or necrosis. Reumatismo (2008) 0.77

Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects. Microb Pathog (2000) 0.77

Clinical experiences with the intramuscular injection of tiaprofenic acid in rheumatic diseases, with particular emphasis on time of onset and duration of the analgesic effect. Drugs (1988) 0.77

UV-A irradiation induces transcription of IL-6 and TNF alpha genes in human keratinocytes and dermal fibroblasts. Rev Rhum Engl Ed (1999) 0.77

Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis (2004) 0.77

Tyrosine kinase participates in phosphorylation of the Ro60 ribonucleoprotein. Rev Rhum Engl Ed (1998) 0.76

Inhibitory effect on endocytosis in polymorphonuclear cells caused by thalidomide. Arch Invest Med (Mex) (1986) 0.76

Intron 2 and exon 3 sequences may be involved in the susceptibility to develop Takayasu arteritis. Int J Cardiol (1998) 0.76

CENP-B autoantigen is a conserved protein from humans to higher plants: identification of the aminoterminal domain in Phaseolus vulgaris. Rev Rhum Engl Ed (1997) 0.75

Interference by rheumatoid factor activity in the detection of antiavian antibodies in pigeon breeders disease. Clin Exp Med (2002) 0.75

Cell-mediated immunity to myoglobin in polymyositis. Ann Rheum Dis (1983) 0.75

Novel concepts of severity mechanisms in ankylosing spondylitis. J Rheumatol (2001) 0.75